Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovary Metastasis”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Testing effectiveness (Phase 2)Ended earlyNCT06478862
What this trial is testing

Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy

Who this might be right for
Cancer of OvaryPancreatic Ductal Adenocarcinoma
Lipomedix Pharmaceuticals Inc. 19
Testing effectiveness (Phase 2)Ended earlyNCT02669914
What this trial is testing

MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors

Who this might be right for
Non-Small Cell Lung CancerNonsmall Cell Lung CancerBreast Cancer+15 more
Washington University School of Medicine 4
Large-scale testing (Phase 3)Study completedNCT01653743
What this trial is testing

Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

Who this might be right for
AnovulationOligo-ovulationHypothalamic-pituitary Dysfunction+1 more
Merck KGaA, Darmstadt, Germany 81
Testing effectiveness (Phase 2)Study completedNCT02001623
What this trial is testing

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Who this might be right for
Ovary CancerCervix CancerEndometrium Cancer+5 more
Seagen Inc. 195
Large-scale testing (Phase 3)Looking for participantsNCT05796973
What this trial is testing

Measuring Oncological Value of Exercise and Statin

Who this might be right for
Prostate CancerBreast CancerKidney Cancer+9 more
Tampere University Hospital 240
Not applicableEnded earlyNCT02052479
What this trial is testing

Insulin Differences Between African-American and Caucasian Female Adolescents With Polycystic Ovary Syndrome (PCOS)

Who this might be right for
Polycystic Ovary SyndromePCOS
Nationwide Children's Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Large-scale testing (Phase 3)Study completedNCT01226394
What this trial is testing

Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients

Who this might be right for
Colorectal Cancer With a Resected Minimal Synchronous PCOvarian MetastasesTumour Rupture in the Abdominal Cavity
Gustave Roussy, Cancer Campus, Grand Paris 150
Early research (Phase 1)Looking for participantsNCT04811703
What this trial is testing

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer

Who this might be right for
Metastatic Ovarian CarcinomaPeritoneal CarcinomatosisStage III Ovarian Cancer+4 more
Hospices Civils de Lyon 15
Not applicableStudy completedNCT06599749
What this trial is testing

Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)

Who this might be right for
Adenocarcinoma of OvaryAdenocarcinoma, TubularPeritoneal Cancer
University Hospital, Basel, Switzerland 80
Testing effectiveness (Phase 2)Looking for participantsNCT04383119
What this trial is testing

Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma

Who this might be right for
Leiomyosarcoma of OvarySoft Tissue Sarcoma
Italian Sarcoma Group 100
Not applicableWithdrawnNCT00402935
What this trial is testing

Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer

Who this might be right for
LeukemiaLong-term Effects Secondary to Cancer Therapy in AdultsLong-term Effects Secondary to Cancer Therapy in Children+5 more
Case Comprehensive Cancer Center
Not applicableStudy completedNCT06161233
What this trial is testing

Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy

Who this might be right for
Renal Cell Carcinoma MetastaticBreast CancerHead and Neck Cancer+4 more
Istituti Clinici Scientifici Maugeri SpA 56
Early research (Phase 1)Study completedNCT05258747
What this trial is testing

A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer

Who this might be right for
Ovarian CancerBreast Cancer
Sandoz 70
Early research (Phase 1)Ended earlyNCT05067972
What this trial is testing

PF-07260437 in Advanced or Metastatic Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsBreast Neoplasms
Pfizer 30
Not applicableStudy completedNCT00444054
What this trial is testing

The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer

Who this might be right for
CancerBreast CancerColon Cancer+3 more
Albert Einstein College of Medicine 10
Testing effectiveness (Phase 2)WithdrawnNCT04276597
What this trial is testing

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.

Who this might be right for
Pulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more
Excel Diagnostics and Nuclear Oncology Center
Testing effectiveness (Phase 2)Ended earlyNCT05001282
What this trial is testing

Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Who this might be right for
Ovarian CancerOvarian NeoplasmsOvarian Carcinoma+22 more
Elucida Oncology 79
Testing effectiveness (Phase 2)Looking for participantsNCT05296564
What this trial is testing

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

Who this might be right for
Sarcoma, SynovialSarcoma,Soft TissueMelanoma Stage IV+6 more
Hadassah Medical Organization 3
Early research (Phase 1)Not Yet RecruitingNCT07715747
What this trial is testing

A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorMetastatic Ovary CancerMetastatic Gastric Cancer+1 more
TJ Biopharma Co., Ltd. 128
Next Page